| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.72B | +7.5% |
| Cost of Revenue | $1.26B | +6.7% |
| Gross Profit | $459.0M | +9.7% |
| R&D Expense | $53.4M | -16.2% |
| SG&A Expense | $185.2M | +5.5% |
| Operating Income | $208.2M | +24.4% |
| Pre-tax Income | $147.6M | +37.5% |
| Income Tax | $26.5M | +59.3% |
| Net Income | $119.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $46.5M | +96.6% |
| Accounts Receivable | $245.3M | +2.9% |
| Inventory | $247.1M | +3.1% |
| Current Assets | $671.1M | +8.7% |
| Total Assets | $3.08B | +4.6% |
| Current Liabilities | $227.2M | +2.8% |
| Long-term Debt | $990.2M | +3.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $205.2M | +13.9% |
| Capital Expenditures | $105.4M | -12.2% |
| Investing Cash Flow | -$195.4M | -19.6% |
| Financing Cash Flow | $13.3M | +173.9% |
| Free Cash Flow | $99.8M | +65.7% |
| +32.3% |
| EPS (Basic) | $3.57 | +31.2% |
| EPS (Diluted) | $3.36 | +24.9% |
| Total Liabilities |
| $1.46B |
| +2.5% |
| Stockholders' Equity | $1.62B | +6.6% |